Source comparison
The Blunt Truth About BPC-157 vs Cortisone Injections Heals Better
Here's the honest answer: cortisone doesn't heal tissue. It masks the problem while the underlying damage persists or worsens. BPC-157 operates through angiogenic and collagen-regulatory pathways that cortisone actively suppresses. If the goal is pain relief t
This comparison does not assign a generated winner or score.
- Here's the honest answer: cortisone doesn't heal tissue. It masks the problem while the underlying damage persists or worsens. BPC-157 operates through angiogenic and collagen-regulatory pathways that cortisone actively suppresses. If the goal is pain relief to maintain function short-term, cortisone wins. If the goal is structural tissue repair with lower re-injury risk, preclinical evidence overwhelmingly favors BPC-157. The peptide isn't FDA-approved for human use, which means researchers bear full responsibility for protocol design, sourcing integrity, and outcome tracking. Cortisone is regulatory-approved, insurance-covered, and clinically standardized. But it doesn't rebuild damaged tendons, ligaments, or muscle. That's not a limitation of the injection technique. It's the mechanism of action.